Skip Nav Destination
Issues
15 March 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Review
Human Cancer Biology
Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer
Sei Hoon Yang; Leah E. Mechanic; Ping Yang; Maria Teresa Landi; Elise D. Bowman; Jason Wampfler; Daoud Meerzaman; Kyeong Man Hong; Felicia Mann; Tatiana Dracheva; Junya Fukuoka; William Travis; Neil E. Caporaso; Curtis C. Harris; Jin Jen
Histologic Type, Organ of Origin, and Wnt Pathway Status: Effect on Gene Expression in Ovarian and Uterine Carcinomas
Kerby A. Shedden; Malti P. Kshirsagar; Donald R. Schwartz; Rong Wu; Hongfeng Yu; David E. Misek; Samir Hanash; Hidetaka Katabuchi; Lora Hedrick Ellenson; Eric R. Fearon; Kathleen R. Cho
Transfer of the sFLT-1 Gene in Morris Hepatoma Results in Decreased Growth and Perfusion and Induction of Genes Associated with Stress Response
Kerstin Schmidt; Johannes Hoffend; Annette Altmann; Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Britta Engelhardt; Dirk Koczan; Jörg Peter; Silke Vorwald; Helmut Eskerski; Michael Eisenhut; Jürgen Metz; Ralf Kinscherf; Uwe Haberkorn
Imaging, Diagnosis, Prognosis
Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
Lynn C. Hartmann; Karen H. Lu; Gerald P. Linette; William A. Cliby; Kimberly R. Kalli; David Gershenson; Robert C. Bast; James Stec; Natalia Iartchouk; David I. Smith; Jeffrey S. Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H. Kaufmann; Edwin A. Clark; Andrew I. Damokosh
Association of NCOA3 Polymorphisms with Breast Cancer Risk
Barbara Burwinkel; Michael Wirtenberger; Rüdiger Klaes; Rita K. Schmutzler; Ewa Grzybowska; Asta Försti; Bernd Frank; Justo Lorenzo Bermejo; Peter Bugert; Barbara Wappenschmidt; Dorota Butkiewicz; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Danuta Mielzynska; Ewa Siwinska; Claus R. Bartram; Kari Hemminki
Microsatellite Instability Testing in Colorectal Carcinoma: Choice of Markers Affects Sensitivity of Detection of Mismatch Repair–Deficient Tumors
Stephanie B. Hatch; Harry M. Lightfoot, Jr.; Christopher P. Garwacki; Dominic T. Moore; Benjamin F. Calvo; John T. Woosley; Janiece Sciarrotta; William K. Funkhouser; Rosann A. Farber
Accurate Discrimination of Barrett's Esophagus and Esophageal Adenocarcinoma Using a Quantitative Three-Tiered Algorithm and Multimarker Real-time Reverse Transcription-PCR
Michael Mitas; Jonas S. Almeida; Kaidi Mikhitarian; William E. Gillanders; David N. Lewin; Demetri D. Spyropoulos; Loretta Hoover; Amanda Graham; Tammy Glenn; Peter King; David J. Cole; Robert Hawes; Carolyn E. Reed; Brenda J. Hoffman
High Gene Expression of TS1, GSTP1, and ERCC1 Are Risk Factors for Survival in Patients Treated with Trimodality Therapy for Esophageal Cancer
Mary-Beth Moore Joshi; Yoshinori Shirota; Kathleen D. Danenberg; Debbi H. Conlon; Dennis S. Salonga; James E. Herndon, II; Peter V. Danenberg; David H. Harpole, Jr.
Stromelysin 3, Ets-1, and Vascular Endothelial Growth Factor Expression in Oral Precancerous and Cancerous Lesions: Correlation with Microvessel Density, Progression, and Prognosis
Shilpi Arora; Jatinder Kaur; Chavvi Sharma; Meera Mathur; Sudhir Bahadur; Nootan K. Shukla; Suryanaryana V.S. Deo; Ranju Ralhan
Cancer Therapy: Clinical
Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B
Ramaswamy Govindan; Robert A. Kratzke; James E. Herndon, II; Gloria A. Niehans; Robin Vollmer; Dorothy Watson; Mark R. Green; Hedy L. Kindler; on behalf of the Cancer and Leukemia Group B (CALGB 30101)
Cancer Therapy: Preclinical
Letters to the Editor
Coxsackievirus and Adenovirus Receptor Expression on Primary Osteosarcoma Specimens and Implications for Gene Therapy with Recombinant Adenoviruses
Harm C.A. Graat; Paul I.J.M. Wuisman; Victor W. van Beusechem; Jan E. Carette; Winald R. Gerritsen; Johannes Bras; Gerard R. Schaap; Gertjan J.L. Kaspers
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.